From BZ’s EVCon Event: XPeng Vice Chairman & President Dr. Brian Gu Now Presenting Live
https://www.youtube.com/watch?v=IOEwtEb2M0M
From BZ’s EVCon Event: Foresight Autonomous Chief Financial Officer, Eli Yoresh And VP Of Business Development, Doron Cohadier Begin Interview
https://www.youtube.com/watch?v=IOEwtEb2M0M
An Inside Look At The Battery Technology Company That ‘Beat Tesla To Mars’
KULR Technology Group Inc (AMEX: KULR) held its "Battery Solutions Day" event on Tuesday afternoon.
The company develops and commercializes high-performance thermal management technologies for electronics, batteries and other components.
Disney Earlier Began Presenting At Goldman Sachs 30th Annual Communacopia Conference
https://thewaltdisneycompany.com/the-walt-disney-company-at-the-goldman-sachs-30th-annual-communacopia-conference/
Disney Earlier Began Presenting At Goldman Sachs 30th Annual Communacopia Conference
https://thewaltdisneycompany.com/the-walt-disney-company-at-the-goldman-sachs-30th-annual-communacopia-conference/
SEC Chair Gary Gensler To Speak Live At 12 p.m. EDT With Washington Post (Live Stream Link)
https://www.washingtonpost.com/washington-post-live/2021/09/21/path-forward-cryptocurrency-with-gary-gensler-us-securities-exchange-commission-chair/
SEC Chair Gary Gensler To Speak Live At 12 p.m. EDT With Washington Post (Live Stream Link)
https://www.washingtonpost.com/washington-post-live/2021/09/21/path-forward-cryptocurrency-with-gary-gensler-us-securities-exchange-commission-chair/
Biogen To Host Virtual Investor R&D Day Tuesday, Sept. 21, 2021
33 early and late-stage clinical programs across modalities and innovative discovery platforms
Uniquely positioned to lead in Alzheimer’s disease with ADUHELM® (aducanumab-avwa) and industry-leading
Immutep to present final Overall Survival data from Phase IIb AIPAC as a Late Breaking Poster Presentation at SITC 2021
Immutep Limited (NASDAQ: IMMP) is pleased to announce it will report final Overall Survival (OS) data from its Phase IIb AIPAC clinical trial evaluating lead product candidate eftilagimod alpha ("efti" or "IMP321") in metastatic breast cancer at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2021.
Co-Diagnostics To Present At Sidoti Virtual Investor Conference Thursday, Sept. 23, 2021 At 3:15 p.m. EDT
Co-Diagnostics, Inc. (NASDAQ:CODX) a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew